Lifeline Biotechnologies Pink Sheet Forecast - Simple Moving Average

LLBO Stock  USD 0.0001  0.0003  75.00%   
The Simple Moving Average forecasted value of Lifeline Biotechnologies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000089 and the sum of the absolute errors of 0.01. Lifeline Pink Sheet Forecast is based on your current time horizon.
  
A two period moving average forecast for Lifeline Biotechnologies is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Lifeline Biotechnologies Simple Moving Average Price Forecast For the 24th of December

Given 90 days horizon, the Simple Moving Average forecasted value of Lifeline Biotechnologies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000089, mean absolute percentage error of 0.00000002, and the sum of the absolute errors of 0.01.
Please note that although there have been many attempts to predict Lifeline Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lifeline Biotechnologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Lifeline Biotechnologies Pink Sheet Forecast Pattern

Backtest Lifeline BiotechnologiesLifeline Biotechnologies Price PredictionBuy or Sell Advice 

Lifeline Biotechnologies Forecasted Value

In the context of forecasting Lifeline Biotechnologies' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lifeline Biotechnologies' downside and upside margins for the forecasting period are 0.000001 and 64.23, respectively. We have considered Lifeline Biotechnologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.000001
Downside
0.0001
Expected Value
64.23
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Lifeline Biotechnologies pink sheet data series using in forecasting. Note that when a statistical model is used to represent Lifeline Biotechnologies pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria96.7628
BiasArithmetic mean of the errors None
MADMean absolute deviation1.0E-4
MAPEMean absolute percentage error0.4434
SAESum of the absolute errors0.0052
The simple moving average model is conceptually a linear regression of the current value of Lifeline Biotechnologies price series against current and previous (unobserved) value of Lifeline Biotechnologies. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Lifeline Biotechnologies

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lifeline Biotechnologies. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00009150.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.00009650.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lifeline Biotechnologies. Your research has to be compared to or analyzed against Lifeline Biotechnologies' peers to derive any actionable benefits. When done correctly, Lifeline Biotechnologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lifeline Biotechnologies.

Other Forecasting Options for Lifeline Biotechnologies

For every potential investor in Lifeline, whether a beginner or expert, Lifeline Biotechnologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lifeline Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lifeline. Basic forecasting techniques help filter out the noise by identifying Lifeline Biotechnologies' price trends.

Lifeline Biotechnologies Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lifeline Biotechnologies pink sheet to make a market-neutral strategy. Peer analysis of Lifeline Biotechnologies could also be used in its relative valuation, which is a method of valuing Lifeline Biotechnologies by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Lifeline Biotechnologies Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lifeline Biotechnologies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lifeline Biotechnologies' current price.

Lifeline Biotechnologies Market Strength Events

Market strength indicators help investors to evaluate how Lifeline Biotechnologies pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lifeline Biotechnologies shares will generate the highest return on investment. By undertsting and applying Lifeline Biotechnologies pink sheet market strength indicators, traders can identify Lifeline Biotechnologies entry and exit signals to maximize returns.

Lifeline Biotechnologies Risk Indicators

The analysis of Lifeline Biotechnologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lifeline Biotechnologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lifeline pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Lifeline Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Lifeline Pink Sheet

  0.57BSX Boston Scientific CorpPairCorr
  0.48EW Edwards Lifesciences CorpPairCorr
  0.47DXCM DexCom IncPairCorr
  0.45SYK StrykerPairCorr
  0.43BRK-A Berkshire HathawayPairCorr
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Lifeline Pink Sheet

Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.